Skip to main content
Clinical Trials/JPRN-UMIN000041510
JPRN-UMIN000041510Completed未知

Clinical application of autogenous demineralized dentin matrix prepared immediately after extraction for alveolar bone regeneration - Clinical application of ADDM after extraction for alveolar bone regeneration

Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences0 sites40 target enrollmentStarted: August 21, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

The clinical application of APDDM prepared immediately after tooth extraction to bone augmentation, taking advantage of the relatively short preparation time due to partial demineralization. APDDM, as introduced in this study, is an efficient, safe, and reasonable bone substitute. Consequently, this material has the potential to become one of the options as a bone substitute in implant dentistry.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 70years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a) Patients who had undergone radiation therapy in the oral and maxillofacial region,b) Patients who had undergone other bone grafting in the surgical area, and who had the history of maxillary sinus disease or symptoms were excluded. c) Patients who had uncontrolled systemic disease were also excluded.

Investigators

Sponsor
Department of Regenerative Oral Surgery, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences

Similar Trials